Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting

BACKGROUND: Upon the COVID-19 pandemic emergence, safety concerns and logistic drawbacks stimulated the search for alternatives to pulse therapy at infusion centres to treat multiple sclerosis relapses. OBJECTIVE: To describe our experience treating multiple sclerosis relapses with a dilute injectab...

Descripción completa

Detalles Bibliográficos
Autores principales: Luetic, Geraldine G., Menichini, María Laura, Fernández, Óscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276560/
https://www.ncbi.nlm.nih.gov/pubmed/34280680
http://dx.doi.org/10.1016/j.msard.2021.103148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276560/
https://www.ncbi.nlm.nih.gov/pubmed/34280680
http://dx.doi.org/10.1016/j.msard.2021.103148

Ejemplares similares